Expression of β-defensins in the canine respiratory tract and antimicrobial activity against Bordetella bronchiseptica

Veterinary Immunology and Immunopathology

Volumn 135, Issue 1-2, 2010, Pages 12-19

  Erles, Kerstin ^a   Brownlie, Joe ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Bordetella bronchiseptica; Defensin; Dog; Respiratory

Indexed keywords

BETA DEFENSIN; BETA DEFENSIN 1; CANINE BETA DEFENSIN 1; CANINE BETA DEFENSIN 103; CANINE BETA DEFENSIN 108; DEFENSIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; POLYPEPTIDE ANTIBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; BORDETELLA BRONCHISEPTICA; BORDETELLA BRONCHISEPTICA INFECTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; DOG DISEASE; DRUG SCREENING; GENE EXPRESSION REGULATION; GENE LOCATION; GENE SEQUENCE; INNATE IMMUNITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT DISEASE;

ANIMALS; BETA-DEFENSINS; BORDETELLA; BORDETELLA INFECTIONS; CELLS, CULTURED; DOG DISEASES; DOGS; LIPOPOLYSACCHARIDES; POLYMERASE CHAIN REACTION; RESPIRATORY MUCOSA; RESPIRATORY TRACT INFECTIONS; TRACHEA; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; BORDETELLA BRONCHISEPTICA; CANINE PARAINFLUENZA VIRUS; CANINE RESPIRATORY CORONAVIRUS; CANIS FAMILIARIS;

EID: 77951208429     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2009.10.025     Document Type: Article

References (39)

1. Banemann A., Deppisch H., Gross R. The lipopolysaccharide of Bordetella bronchiseptica acts as a protective shield against antimicrobial peptides. Infect. Immun. 1998, 66:5607-5612.
2. Buonavoglia C., Martella V. Canine respiratory viruses. Vet. Res. 2007, 38:355-373.
3. Candille S.I., Kaelin C.B., Cattanach B.M., Yu B., Thompson D.A., Nix M.A., Kerns J.A., Schmutz S.M., Millhauser G.L., Barsh G.S. A β-defensin mutation causes black coat color in domestic dogs. Science 2007, 318:1418-1423.
4. Chalker V.J., Brooks H.W., Brownlie J. The association of Streptococcus equi subsp. zooepidemicus with canine infectious respiratory disease. Vet. Microbiol. 2003, 95:149-156.
5. Chalker V.J., Owen W.M., Paterson C., Barker E., Brooks H., Rycroft A.N., Brownlie J. Mycoplasmas associated with canine infectious respiratory disease. Microbiology 2004, 150:3491-3497.
6. Chalker V.J., Toomey C., Opperman S., Brooks H.W., Ibuoye M.A., Brownlie J., Rycroft A.N. Respiratory disease in kennelled dogs: serological responses to Bordetella bronchiseptica lipopolysaccharide do not correlate with bacterial isolation or clinical respiratory symptoms. Clin. Diagn. Lab. Immunol. 2003, 10:352-356.
7. Charoenvit Y., Brice G.T., Bacon D., Majam V., Williams J., Abot E., Ganeshan H., Sedegah M., Doolan D.L., Carucci D.J., Zimmerman D.H. A small peptide (CEL-1000) derived from the beta-chain of the human major histocompatibility complex class II molecule induces complete protection against malaria in an antigen-independent manner. Antimicrob. Agents Chemother. 2004, 48:2455-2463.
8. Chong K.T., Thangavel R.R., Tang X. Enhanced expression of murine [beta]-defensins (MBD-1, -2,- 3, and -4) in upper and lower airway mucosa of influenza virus infected mice. Virology 2008, 380:136-143.
9. Chong K.T., Xiang L., Wang X., Jun E.L., Xi L.F., Schweinfurth J.M. High level expression of human epithelial beta-defensins (hBD-1, 2 and 3) in papillomavirus induced lesions. Virol. J. 2006, 3:75.
10. Crawford P.C., Dubovi E.J., Castleman W.L., Stephenson I., Gibbs E.P.J., Chen L., Smith C., Hill R.C., Ferro P., Pompey J., Bright R.A., Medina M.-J., Johnson C.M., Olsen C.W., Cox N.J., Klimov A.I., Katz J.M., Donis R.O. Transmission of equine influenza virus to dogs. Science 2005, 310:482-485. 10.1126/science.1117950.
11. Diamond G., Kaiser V., Rhodes J., Russell J.P., Bevins C.L. Transcriptional regulation of beta-defensin gene expression in tracheal epithelial cells. Infect. Immun. 2000, 68:113-119.
12. Erles K., Dubovi E.J., Brooks H.W., Brownlie J. Longitudinal study of viruses associated with canine infectious respiratory disease. J. Clin. Microbiol. 2004, 42:4524-4529.
13. Erles K., Toomey C., Brooks H.W., Brownlie J. Detection of a group 2 coronavirus in dogs with canine infectious respiratory disease. Virology 2003, 310:216-223.
14. Frisk A.L., Konig M., Moritz A., Baumgartner W. Detection of canine distemper virus nucleoprotein RNA by reverse transcription-PCR using serum, whole blood, and cerebrospinal fluid from dogs with distemper. J. Clin. Microbiol. 1999, 37:3634-3643.
15. Fritz J.H., Brunner S., Birnstiel M.L., Buschle M., Gabain A., Mattner F., Zauner W. The artificial antimicrobial peptide KLKLLLLLKLK induces predominantly a TH2-type immune response to co-injected antigens. Vaccine 2004, 22:3274-3284.
16. Froy O. Regulation of mammalian defensin expression by Toll-like receptor-dependent and independent signalling pathways. Cell Microbiol. 2005, 7:1387-1397.
17. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 2003, 3:710-720.
18. Grubor B., Gallup J.M., Meyerholz D.K., Crouch E.C., Evans R.B., Brogden K.A., Lehmkuhl H.D., Ackermann M.R. Enhanced surfactant protein and defensin mRNA levels and reduced viral replication during parainfluenza virus type 3 pneumonia in neonatal lambs. Clin. Diagn. Lab. Immunol. 2004, 11:599-607.
19. Harder J., Bartels J., Christophers E., Schroder J.-M. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 2001, 276:5707-5713.
20. Jacobs A.A., Theelen R.P., Jaspers R., Horspool L.J., Sutton D., Bergman J.G., Paul G. Protection of dogs for 13 months against Bordetella bronchiseptica and canine parainfluenza virus with a modified live vaccine. Vet. Rec. 2005, 157:19-23.
21. Kawashima K., Meyerholz D.K., Gallup J.M., Grubor B., Lazic T., Lehmkuhl H.D., Ackermann M.R. Differential expression of ovine innate immune genes by preterm and neonatal lung epithelia infected with respiratory syncytial virus. Viral Immunol. 2006, 19:316-323.
22. Knowles M.R., Robinson J.M., Wood R.E., Pue C.A., Mentz W.M., Wager G.C., Gatzy J.T., Boucher R.C. Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease-control subjects. J. Clin. Invest. 1997, 100:2588-2595.
23. Kobayashi H., Yamamoto K., Eguchi M., Kubo M., Nakagami S., Wakisaka S., Kaizuka M., Ishii H. Rapid detection of mycoplasma contamination in cell cultures by enzymatic detection of polymerase chain reaction (PCR) products. J. Vet. Med. Sci. 1995, 57:769-771.
24. Krishnakumari V., Singh S., Nagaraj R. Antibacterial activities of synthetic peptides corresponding to the carboxy-terminal region of human [beta]-defensins 1-3. Peptides 2006, 27:2607-2613.
25. Leikina E., Delanoe-Ayari H., Melikov K., Cho M.S., Chen A., Waring A.J., Wang W., Xie Y., Loo J.A., Lehrer R.I., Chernomordik L.V. Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins. Nat. Immunol. 2005, 6:995-1001.
26. Maisetta G., Di Luca M., Esin S., Florio W., Brancatisano F.L., Bottai D., Campa M., Batoni G. Evaluation of the inhibitory effects of human serum components on bactericidal activity of human beta defensin 3. Peptides 2008, 29:1-6.
27. Pivarcsi A., Nagy I., Koreck A., Kis K., Kenderessy-Szabo A., Szell M., Dobozy A., Kemeny L. Microbial compounds induce the expression of pro-inflammatory cytokines, chemokines and human [beta]-defensin-2 in vaginal epithelial cells. Microb. Infect. 2005, 7:1117-1127.
28. Priestnall S.L., Mitchell J.A., Brooks H.W., Brownlie J., Erles K. Quantification of mRNA encoding cytokines and chemokines and assessment of ciliary function in canine tracheal epithelium during infection with canine respiratory coronavirus (CRCoV). Vet. Immunol. Immunopathol. 2009, 127:38-46.
29. Proud D., Sanders S.P., Wiehler S. Human rhinovirus infection induces airway epithelial cell production of human beta-defensin 2 both in vitro and in vivo. J. Immunol. 2004, 172:4637-4645.
30. Quinones-Mateu M.E., Lederman M.M., Feng Z., Chakraborty B., Weber J., Rangel H.R., Marotta M.L., Mirza M., Jiang B., Kiser P., Medvik K., Sieg S.F., Weinberg A. Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. Aids 2003, 17:F39-48.
31. Sang Y., Ortega M.T., Blecha F., Prakash O., Melgarejo T. Molecular cloning and characterization of three beta-defensins from canine testes. Infect. Immun. 2005, 73:2611-2620.
32. Sang Y., Ruchala P., Lehrer R.I., Ross C.R., Rowland R.R., Blecha F. Antimicrobial host defense peptides in an arteriviral infection: differential peptide expression and virus inactivation. Viral Immunol. 2009, 22:235-242.
33. Schutte B.C., McCray P.B. [beta]-defensins in lung host defense. Annu. Rev. Physiol. 2002, 64:709-748.
34. Seville M., West A.B., Cull M.G., McHenry C.S. Fluorometric assay for DNA polymerases and reverse transcriptase. Biotechniques 1996, 21:664-672.
35. Singh P.K., Jia H.P., Wiles K., Hesselberth J., Liu L., Conway B.A., Greenberg E.P., Valore E.V., Welsh M.J., Ganz T., Tack B.F., McCray P.B. Production of beta-defensins by human airway epithelia. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:14961-14966.
36. Smith J.J., Travis S.M., Greenberg E.P., Welsh M.J. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 1996, 85:229-236.
37. Tsutsumi-Ishii Y., Nagaoka I. Modulation of human {beta}-defensin-2 transcription in pulmonary epithelial cells by lipopolysaccharide-stimulated mononuclear phagocytes via proinflammatory cytokine production. J. Immunol. 2003, 170:4226-4236.
38. Whelan J.A., Russell N.B., Whelan M.A. A method for the absolute quantification of cDNA using real-time PCR. J. Immunol. Methods 2003, 278:261-269.
39. Wingate K.V., Torres S.M., Silverstein K.A., Hendrickson J.A., Rutherford M.S. Expression of endogenous antimicrobial peptides in normal canine skin. Vet. Dermatol. 2009, 20:19-26.